NCT02031003

Brief Summary

  • The primary objective of the study was to compare stool composition (stool soap and non-soap fatty acids, total fatty acids, minerals, and other stool constituents) of infants randomized to receive either standard formula, or 1 of 2 innovative formulas containing a new fat blend or the new fat blend plus fiber.
  • The secondary objectives were to evaluate among the feeding groups, stool characteristics (stool consistency and frequency), GI tolerance assessed by the Infant Gastrointestinal Symptom Questionnaire (IGSQ), and urinary markers (F2-isoprostanes and 8-hydroxy-2'-deoxyguanosine \[8-OHdG\], and urine osmolality and specific gravity).
  • The primary safety objective was to describe the frequency of adverse events (AEs) among the formula-fed (FF) groups.
  • The secondary safety objective was to describe anthropometric measures (weight, length, and head circumference) among the feeding groups.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
220

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2010

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2010

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2011

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

December 23, 2013

Completed
17 days until next milestone

First Posted

Study publicly available on registry

January 9, 2014

Completed
Last Updated

March 13, 2026

Status Verified

March 1, 2026

Enrollment Period

1.2 years

First QC Date

December 23, 2013

Last Update Submit

March 10, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Stool Composition

    Stool soap and non-soap fatty acids, total fatty acids, minerals, and other stool constituents

    Day 28

Secondary Outcomes (8)

  • Stool Consistency determined using a 3-day stool diary

    Days 14 and 28

  • Stool frequency determined using a 3-day stool diary

    Day 14 and 28

  • GI Tolerance

    Baseline, Day 14 and Day 28

  • Incidence of adverse events

    From ICF signing until 14 days after last study feeding

  • Anthropometric measurements

    Baseline, Day 14 and Day 28

  • +3 more secondary outcomes

Study Arms (4)

Control

OTHER

Standard infant formula

Dietary Supplement: Infant formula

Experimental 1

EXPERIMENTAL

Standard infant formula containing a new fat blend

Dietary Supplement: Infant formula

Experimental 2

EXPERIMENTAL

Standard infant formula containing a new fat blend and fiber

Dietary Supplement: Infant formula

Human Milk (HM)

NO INTERVENTION

Non-randomized Human Milk group

Interventions

Infant formulaDIETARY_SUPPLEMENT

Infant formula

ControlExperimental 1Experimental 2

Eligibility Criteria

Age25 Days - 45 Days
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Healthy, term (no less than 37 weeks and no greater than 42 weeks) singleton infants; between 25 days to 45 days post natal age (date of birth = Day 0) and weight for age ≥3rd and ≤97th percentiles according to Taiwan growth charts at the time of study entry.
  • Human milk fed infants were exclusively consuming and tolerating HM and the mother must have made the decision to continue to exclusively breastfeed.
  • Formula-fed infants were exclusively consuming and tolerating a cow's milk infant formula and parents/LAR must have previously made the decision to continue to exclusively formula feed.

You may not qualify if:

  • Infants receiving any amount of supplemental HM with infant formula feeding or vice versa
  • Family history of siblings with documented cow's milk protein intolerance/allergy
  • Major congenital malformations, suspected or documented systemic or congenital infections, evidence systemic diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Chang Gung Medical Foundation - LinKou Branch

Linkou District, Tao-Yuan County, Taiwan

Location

Mackay Memorial Hospital - Hsinchu Branch

Hsinchu, Taiwan

Location

Chang Gung Medical Foundation, Taipei Branch

Taipei, Taiwan

Location

Mackay Memorial Hospital

Taipei, Taiwan

Location

Related Publications (1)

  • Nowacki J, Lee HC, Lien R, Cheng SW, Li ST, Yao M, Northington R, Jan I, Mutungi G. Stool fatty acid soaps, stool consistency and gastrointestinal tolerance in term infants fed infant formulas containing high sn-2 palmitate with or without oligofructose: a double-blind, randomized clinical trial. Nutr J. 2014 Nov 5;13:105. doi: 10.1186/1475-2891-13-105.

MeSH Terms

Conditions

Bottle Feeding

Interventions

Infant Formula

Condition Hierarchy (Ancestors)

Feeding BehaviorBehavior

Intervention Hierarchy (Ancestors)

Milk SubstitutesBeveragesDiet, Food, and NutritionPhysiological PhenomenaFood, FormulatedFoods, SpecializedFoodInfant FoodFood and Beverages

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 23, 2013

First Posted

January 9, 2014

Study Start

September 1, 2010

Primary Completion

December 1, 2011

Study Completion

December 1, 2011

Last Updated

March 13, 2026

Record last verified: 2026-03

Locations